SCHEMBL30724459

SCHEMBL30724459

CCOC(=O)c1ccc2c(c1)nc(Cl)c1[nH]cc(C(=O)OCC)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
HPGD P15428 3/20 0.45
TP53 P04637 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HSD17B10 Q99714 2/20 0.45
IMPDH2 P12268 1/20 0.43
KDM4E B2RXH2 3/20 0.43
CLEC4M Q9H2X3 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
SIRT3 Q9NTG7 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
JAK2 O60674 4/20 0.41
JAK3 P52333 4/20 0.41
NPC1 O15118 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30885770 0.79 ALDH1A1 (0.48) ALDH1A1HPGDTP53L3MBTL1MEN1
SCHEMBL30802436 0.76 CDK1 (0.50) ALDH1A1HPGDTP53L3MBTL1MEN1
SCHEMBL30745641 0.76 PKN1 (0.47) ALDH1A1HPGDL3MBTL1MEN1KMT2A
SCHEMBL30724462 0.75 ALDH1A1 (0.52) ALDH1A1HPGDTP53L3MBTL1MEN1
SCHEMBL20588653 0.74 ALDH1A1 (0.53) ALDH1A1HPGDTP53L3MBTL1MEN1
SCHEMBL31095354 0.74 ALDH1A1 (0.53) ALDH1A1HPGDTP53L3MBTL1MEN1
SCHEMBL1458735 0.74 ALDH1A1 (0.58) ALDH1A1HPGDL3MBTL1HSD17B10KDM4E
SCHEMBL30717946 0.74 ALDH1A1 (0.56) ALDH1A1HPGDTP53L3MBTL1MEN1
SCHEMBL31472839 0.74 ALDH1A1 (0.50) ALDH1A1HPGDTP53L3MBTL1MEN1
SCHEMBL18706180 0.72 ALDH1A1 (0.53) ALDH1A1HPGDTP53L3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11878978-B1 Pyrrolo[2,3-c]quinoline compounds as CK2 inhibitors King Faisal University (SA) 2024-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11878978-B1 Pyrrolo[2,3-c]quinoline compounds as CK2 inhibitors CSNK2A3, SKP2, CKS2 ALDH1A1 4762/4885HPGD 3830/4885TP53 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.